These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 30586302)

  • 1. How Can Interleukin-1 Receptor Antagonist Modulate Distinct Cell Death Pathways?
    Spinello A; Vecile E; Abbate A; Dobrina A; Magistrato A
    J Chem Inf Model; 2019 Jan; 59(1):351-359. PubMed ID: 30586302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloid formation disrupts the balance between interleukin-1β and interleukin-1 receptor antagonist in human islets.
    Hui Q; Asadi A; Park YJ; Kieffer TJ; Ao Z; Warnock GL; Marzban L
    Mol Metab; 2017 Aug; 6(8):833-844. PubMed ID: 28752047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-1 receptor antagonist inhibits angiogenesis in gastric cancer.
    Gong Z; Ma J; Su H; Guo T; Cai H; Chen Q; Zhao X; Qi J; Du J
    Int J Clin Oncol; 2018 Aug; 23(4):659-670. PubMed ID: 29344744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allosteric switching of agonist/antagonist activity by a single point mutation in the interluekin-1 receptor antagonist, IL-1Ra.
    Hailey KL; Capraro DT; Barkho S; Jennings PA
    J Mol Biol; 2013 Jul; 425(13):2382-92. PubMed ID: 23499887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-15 delays human neutrophil apoptosis by intracellular events and not via extracellular factors: role of Mcl-1 and decreased activity of caspase-3 and caspase-8.
    Bouchard A; Ratthé C; Girard D
    J Leukoc Biol; 2004 May; 75(5):893-900. PubMed ID: 14982947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of interleukin-1 receptor antagonist protection against myocardial ischaemia/reperfusion-induced injury.
    Qian W; Zhao C; Li D; Dai R
    Arch Cardiovasc Dis; 2018 Oct; 111(10):545-554. PubMed ID: 29724623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-1 receptor antagonist (IL-1Ra) and IL-1Ra producing mesenchymal stem cells as modulators of diabetogenesis.
    Volarevic V; Al-Qahtani A; Arsenijevic N; Pajovic S; Lukic ML
    Autoimmunity; 2010 Jun; 43(4):255-63. PubMed ID: 19845478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of inflammation after administration of interleukin-1 receptor antagonist following aneurysmal subarachnoid hemorrhage: results of the Subcutaneous Interleukin-1Ra in SAH (SCIL-SAH) study.
    Galea J; Ogungbenro K; Hulme S; Patel H; Scarth S; Hoadley M; Illingworth K; McMahon CJ; Tzerakis N; King AT; Vail A; Hopkins SJ; Rothwell N; Tyrrell P
    J Neurosurg; 2018 Feb; 128(2):515-523. PubMed ID: 28298024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-1 Receptor Antagonist Chimeric Protein: Context-Specific and Inflammation-Restricted Activation.
    Rider P; Carmi Y; Yossef R; Guttman O; Eini H; Azam T; Dinarello CA; Lewis EC
    J Immunol; 2015 Aug; 195(4):1705-12. PubMed ID: 26157171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocyte-specific deletion of IL1-RI attenuates liver injury by blocking IL-1 driven autoinflammation.
    Gehrke N; Hövelmeyer N; Waisman A; Straub BK; Weinmann-Menke J; Wörns MA; Galle PR; Schattenberg JM
    J Hepatol; 2018 May; 68(5):986-995. PubMed ID: 29366909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential binding of human interleukin-1 (IL-1) receptor antagonist to natural and recombinant soluble and cellular IL-1 type I receptors.
    Svenson M; Nedergaard S; Heegaard PM; Whisenand TD; Arend WP; Bendtzen K
    Eur J Immunol; 1995 Oct; 25(10):2842-50. PubMed ID: 7589081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural differences between the putative carbohydrate-recognition domains of human IL-1 alpha, IL-1 beta and IL-1 receptor antagonist obtained by in silico modeling.
    Vergoten G; Zanetta JP
    Glycoconj J; 2007 Jul; 24(4-5):183-93. PubMed ID: 17340198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell therapy centered on IL-1Ra is neuroprotective in experimental stroke.
    Clausen BH; Lambertsen KL; Dagnæs-Hansen F; Babcock AA; von Linstow CU; Meldgaard M; Kristensen BW; Deierborg T; Finsen B
    Acta Neuropathol; 2016 May; 131(5):775-91. PubMed ID: 26860727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of interleukin-1 (alpha and beta), interleukin-2 secretion and surface expression of interleukin-2 receptor (IL-2R) by a novel cytokine interleukin-1 receptor antagonist (IL-1ra).
    Conti P; Panara MR; Porrini AM; Gambi D; Barbacane RC; Reale M; Bongrazio M; Dempsey RA
    Scand J Immunol; 1992 Jul; 36(1):27-33. PubMed ID: 1535451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A functional interleukin-1 receptor antagonist polymorphism influences atherosclerosis development. The interleukin-1beta:interleukin-1 receptor antagonist balance in atherosclerosis.
    Olofsson PS; Sheikine Y; Jatta K; Ghaderi M; Samnegård A; Eriksson P; Sirsjö A
    Circ J; 2009 Aug; 73(8):1531-6. PubMed ID: 19574724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An anti-inflammatory property of Candida albicans β-glucan: Induction of high levels of interleukin-1 receptor antagonist via a Dectin-1/CR3 independent mechanism.
    Smeekens SP; Gresnigt MS; Becker KL; Cheng SC; Netea SA; Jacobs L; Jansen T; van de Veerdonk FL; Williams DL; Joosten LA; Dinarello CA; Netea MG
    Cytokine; 2015 Feb; 71(2):215-22. PubMed ID: 25461401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunolocalization of interleukin-1 receptor antagonist in healthy and infarcted myocardium.
    Bonetti A; Marchini M; Ortolani F
    Histol Histopathol; 2008 Sep; 23(9):1093-102. PubMed ID: 18581280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Interleukin-1 Family.
    Yazdi AS; Ghoreschi K
    Adv Exp Med Biol; 2016; 941():21-29. PubMed ID: 27734407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autocrine interleukin-1 receptor antagonist can support malignant growth of glioblastoma by blocking growth-inhibiting autocrine loop of interleukin-1.
    Oelmann E; Kraemer A; Serve H; Reufi B; Oberberg D; Patt S; Herbst H; Stein H; Thiel E; Berdel WE
    Int J Cancer; 1997 Jun; 71(6):1066-76. PubMed ID: 9185713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-1 receptor antagonist.
    Arend WP
    Adv Immunol; 1993; 54():167-227. PubMed ID: 8379462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.